DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 9.259,430 B2 Rathmacher Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 9.259,430 B2 Rathmacher Et Al US00925943OB2 (12) United States Patent (10) Patent No.: US 9.259,430 B2 Rathmacher et al. (45) Date of Patent: *Feb. 16, 2016 (54) NUTRITIONAL INTERVENTION FOR (56) References Cited IMPROVING MUSCULAR FUNCTION AND STRENGTH U.S. PATENT DOCUMENTS 4,992.470 A 2f1991 Nissen (71) Applicant: Metabolic Technologies, Inc., Ames, IA 5,028,440 A 7, 1991 Nissen (US) 5,087.472 A 2f1992 Nissen 5,348,979 A 9, 1994 Nissen et al. 5,360,613 A 11/1994 Nissen (72) Inventors: John Rathmacher, Story City, IA (US); 6,031,000 A 2/2000 Nissen et al. John Fuller, Jr., Zearing, IA (US); 6,103,764 A 8, 2000 Nissen Shawn Baier, Polk City, IA (US); Steve 6,291525 B1 9, 2001 Nissen 8,815,280 B2 * 8/2014 Rathmacher et al. ......... 424/439 Nissen, Ames, IA (US); Naji Abumrad, 2004f0071825 A1 4/2004 Lockwood Nashville, IA (US) 2005/0215640 A1 9, 2005 Baxter et al. 2006, OOO3947 A1 1, 2006 Udell (73) Assignee: Metabolic Technologies, Inc., Ames, IA 2007/0142469 A1 6/2007 Thomas et al. (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 WO 2008024456 A2 2, 2008 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS This patent is Subject to a terminal dis McCarty et al. (“Toward a Core Nutraceutical Program for Cancer claimer. Management” in Integrative Cancer Therapies 5(2); 2006.* Krebs, H. A. & Lund, P. (1977) Aspects of the regulation of the metabolism of branched-chain amino acids. Advan. Enzyme Regul. (21) Appl. No.: 14/219,522 15:375-394. Harper, A. E., Benevenga, N.J. & Wohlhueter, R. M. (1970) Effects (22) Filed: Mar 19, 2014 of ingestion of disproportionate amounts of amino acids. Physiol. Rev. 53: 428-558. (65) Prior Publication Data Nissen, S. L. & Abumrad, N. N. (1997) Nutritional role of the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB). J. Nutr. US 2015/OO25047 A1 Jan. 22, 2015 Biochem. 8:300-311. Nissen, S., Sharp, R. Ray, M., Rathmacher, J. A., Rice, J., Fuller, J. C., Jr., Connelly, A. S. & Abumrad, N. N. (1996) The effect of the Related U.S. Application Data leucine metabolite beta-hydroxy beta-methylbutyrate on muscle metabolism during resistance-exercise training. J. Appl. Physiol. (63) Continuation-in-part of application No. 12/634,507, 81(5): 2095-2104. filed on Dec. 9, 2009, now Pat. No. 8,815,280. Nissen, S., Van Koevering, M. & Webb, D. (1990) Analysis of beta hydroxy-beta-methylbutyrate in plasma by gas chromatography and (60) Provisional application No. 61/121,065, filed on Dec. mass spectrometry. Anal. Biochem. 188: 17-19. 9, 2008. Frexes-Steed, M., Warner, M.L., Bulus, N., Flakoll, P. & Abumrad, N. N. (1990) Role of insulin and branched-chain amino acids in regu (51) Int. Cl. lating protein metabolism during fasting. Am. J. Physiol. A 6LX3/59 (2006.01) (Endocrinol. Metab.) 258: E907-E917. A6 IK3I/9 (2006.01) Robinson, W. G. Bachhawat, B.K. & Coon, M.J. (1954) Enzymatic A2.3L I/302 (2006.01) carbon dioxide fixation by senecioyl coenzyme A. Fed. Proc. 13:281. A2.3L I/303 (2006.01) (Continued) A2.3L I/305 (2006.01) Primary Examiner — Blessing MFubara A2.3L I/30 (2006.01) (74) Attorney, Agent, or Firm — Davis Brown Law Firm; A23K L/I6 (2006.01) Emily Harris (52) U.S. Cl. CPC. A61 K3I/59 (2013.01); A23K 1/16 (2013.01); (57) ABSTRACT A23K 1/1603 (2013.01); A23L 1/30 (2013.01); The present invention provides a composition comprising A23L I/302 (2013.01); A23L I/303 (2013.01); HMB and Vitamin D. Methods of administering HMB and A23L I/3051 (2013.01); A61K 31/19 (2013.01); Vitamin D to an animal are also described. Vitamin D and A23 V 2002/00 (2013.01) HMB are administered to increase muscle mass, strength, and (58) Field of Classification Search functionality. The combination of Vitamin D and HMB CPC ........ A61K 3 1/59; A61K 31/19: A23L 1/302: together has a synergistic effect, which results in a Surprising A23L 1/303: A23L 1/3051, A23L 1/30; and unexpected level of improvement in muscle mass, A23K 1/16: A23K 1/1603 strength and functionality. See application file for complete search history. 20 Claims, 8 Drawing Sheets US 9.259,430 B2 Page 2 (56) References Cited Eley, H. L. Russell, S.T., Baxter, J. H. Mukherji, P. & Tisdale, M. J. (2007) Signaling pathways initiated by beta-hydroxy-beta OTHER PUBLICATIONS methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am. J. Physiol Rudney, H. & Farkas, T. G. (1955) Biosynthesis of branched chain Endocrinol. Metab 293: E923-E931. acids. Fed. Proc. Sep. 757-759. Smith, H. J., Mukerji, P. & Tisdale, M. J. (2005) Attenuation of Rabinowitz, J. L., Dituri, F. Cobey, F. & Gurin, S. (1955) Branched proteasome-induced proteolysis in skeletal muscle by beta-hydroxy chain acids in the biosynthesis of squalene and cholesterol. Fed. Proc. beta-methylbutyrate in cancer-induced muscle loss. Cancer Res.65: 14: 760-761. 277-283. Coon, M.J. (1955) Enzymatic synthesis ofbranched chain acids from amino acids. Fed. Proc. 14: 762-764. Smith, H. J. Wyke, S. M. & Tisdale, M.J. (2004) Mechanism of the Gey, K. F. Pletsher, A., Isler, O. Ruegg, R. & Wursch, J. (1957) The attenuation of proteolysis-inducing factor stimulated protein degra influence of isoperenic C5 and C6 compounds upon the acetate dation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res. incorporation into cholesterol. Helvetica Chim. Acta 40: 2354-2368. 64: 8731-8735. Gey, K. F., Pletsher, A., Isler, O. Ruegg, R. & Wursch, J. (1957) Eley, H. L. Russell, S. T. & Tisdale, M. J. (2008) Mechanism of Influence ofiosoprenoid C5 and C6 compounds on the incorporation Attenuation of Muscle Protein Degradation Induced by Tumor of acetate in cholesterol. Helvetica Chim. Acta 40: 2354-2368. Necrosis Factor Alpha and Angiotensin II by beta-Hydroxy-beta Isler, O. Ruegg, R., Wursch, J., Gey, K. F. & Pletsher, A. (1957) methylbutyrate. Am. J. Physiol Endocrinol. Metab 295: E 1417 Biosynthesis of cholesterol from beta, t-dihydroxy-beta E1426. methylvaleric acid. Helvetica Chim. Acta 40: 2369-2373. Eley, H. L. Russell, S. T. & Tisdale, M. J. (2008) Attenuation of Zabin, I. & Bloch, K. (1951) The utilization of butyric acid for the depression of muscle protein synthesis induced by lipopolysac synthesis of cholesterol and fatty acids. J. Biol. Chem. 192:261-266. charide, tumor necrosis factor and angiotensin II by beta-hydroxy Plaut, G. W. E. & Lardy, H. A. (1951) Enzymatic incorporation of beta-methylbutyrate. Am. J. Physiol Endocrinol. Metab 295: E1409 C14-bicarbonate into acetoacetate in the presence of various Sub E1416. Strates. J. Biol. Chem. 192: 435-445. Nissen, S. L. & Sharp, R. L. (2003) Effect of dietary Supplements on Bloch, K., Clark, L. C. & Haray, I. (1954) Utilization of branched lean mass and strength gains with resistance exercise: a meta-analy chain acids in cholesterol synthesis. J. Biol. Chem. 211: 687-699. sis. J Appl. Physiol 94: 651-659. Rudney, H. (1954) The synthesis of beta-hydroxy-beta Kreider, R., Ferreira, M., Wilson, M. & Almada, A. (1999) Effects of methylglutaric acid in rat liver homogenates. J. Am. Chem. Soc. 76: calcium beta-hydroxy-beta-methylbutyrate (HMB) supplementation 2595. during resistance-training on markers of catabolism, body composi Bachhawat, B. K. Robinson, W. G. & Coon, M. J. (1955) The tion and strength. IntJ Sports Med 20: 503-509. enzymatic cleavage of beta-hydroxy-beta-methylglutaryl coenzyme Gallagher, P. M., Carrithers, J. A., Godard, M. P. Schutze, K. E. & a to aceto-acetate and acetyl coenzyme A. J. Biol. Chem. 216: 727 Trappe, S. W. (2000) beta-Hydroxy-beta-methylbutyrate ingestion, T36. Part II: Effects on hematology, hepatic, and renal function. MedSci McAllan, A. B. & Smith, R. H. (1984) The efficiency of microbial Sports Exerc 32(12): 2116-2119. protein synthesis in the rumen and the degradability offeed nitrogen Nissen, S. Panton, L., Sharp, R. L., Vukovich, M., Trappe, S.W. & between the mouth and abomasum in steers given different diets. Br. Fuller, J. C., Jr. (2000) beta-Hydroxy-beta-methylbutyrate (HMB) J. Nutr. 51: 77-83. Supplementation in humans is safe and may decrease cardiovascular Adamson, L. F. & Greenberg, D. M. (1957) The significance of risk factors. J Nutr 130: 1937-1945. certain carboxylic acids as intermediates in the biosynthesis of cho Rathmacher, J. A., Nissen, S., Panton, L., Clark, R. H., Eubanks, M. lesterol. Biochim. Biophys. Acta 23: 472-479. P. Barber, A. E., D'Olimpio, J. & Abumrad, N. N. (2004) Supple Jowko, E. et al. (2001) Creatine and beta hydroxy-beta mentation with a combination of beta-hydroxy-beta-methylbutyrate methylbutyrate (HMB) additively increases lean body mass and (HMB), arginine, and glutamine is safe and could improve muscle strength during a weight training program. Nutr. 17:558-566. hematological parameters. JPENJ Parenter Enteral Nutr 28: 65-75. Knitter, A. E. et al. (2000) Effects of beta-hyroxy-methylbutyrate on Eubanks May, P. Barber, A., Hourihane, A., D'Olimpio, J. T. & muscle damage following a prolonged run. J. Appl. Physiol. 89(4): Abumrad, N. N. (2002) Reversal of cancer-related wasting using oral 1340-1344. Supplementation with a combination of beta-hydroxy-beta Gallagher, P. M., Carrithers, J. A., Godard, M. P. Schulze, K. E. & methylbutyrate, arginine, and glutamine. Am. J. Surg. 183: 471-479. Trappe, S. W. (2000) beta-Hydroxy-betamethylbutyrate ingestion, Clark, R. H., Feleke, G., Din, M.Yasmin, T. Singh, G. Khan, F. & Part I: Effects on strength and fat free mass. MedSci Sports Exerc Rathmacher, J.
Load more

Recommended publications
  • Calcium Chloride CAS N°:10043-52-4
    OECD SIDS CALCIUM CHLORIDE FOREWORD INTRODUCTION Calcium chloride CAS N°:10043-52-4 UNEP PUBLICATIONS 1 OECD SIDS CALCIUM CHLORIDE SIDS Initial Assessment Report For SIAM 15 Boston, USA 22-25th October 2002 1. Chemical Name: Calcium chloride 2. CAS Number: 10043-52-4 3. Sponsor Country: Japan National SIDS Contact Point in Sponsor Country: Mr. Yasuhisa Kawamura Director Second Organization Div. Ministry of Foreign Affairs 2-2-1 Kasumigaseki, Chiyoda-ku Tokyo 100 4. Shared Partnership with: 5. Roles/Responsibilities of the Partners: • Name of industry sponsor Tokuyama Corporation /consortium Mr. Shigeru Moriyama, E-mail: [email protected] Mr. Norikazu Hattori, E-mail: [email protected] • Process used 6. Sponsorship History • How was the chemical or This substance is sponsored by Japan under ICCA Initiative and category brought into the is submitted for first discussion at SIAM 15. OECD HPV Chemicals Programme ? 7. Review Process Prior to The industry consortium collected new data and prepared the the SIAM: updated IUCLID, and draft versions of the SIAR and SIAP. Japanese government peer-reviewed the documents, audited selected studies. 8. Quality check process: 9. Date of Submission: 10. Date of last Update: 2 UNEP PUBLICATIONS OECD SIDS CALCIUM CHLORIDE 11. Comments: No testing (X) Testing ( ) The CaCl2-HPV Consortium members: (Japan) Asahi Glass Co., Ltd. Central Glass Co., Ltd. Sanuki Kasei Co., Ltd. Tokuyama Corporation [a global leader of the CaCl2-HPV Consortium] Tosoh Corporation (Europe) Brunner Mond (UK) Ltd. Solvay S.A. (North America) The Dow Chemical Company General Chemical Industrial Products Inc. Tetra Technologies, Inc.
    [Show full text]
  • US EPA Inert (Other) Pesticide Ingredients
    U.S. Environmental Protection Agency Office of Pesticide Programs List of Inert Pesticide Ingredients List 3 - Inerts of unknown toxicity - By Chemical Name UpdatedAugust 2004 Inert Ingredients Ordered Alphabetically by Chemical Name - List 3 Updated August 2004 CAS PREFIX NAME List No. 6798-76-1 Abietic acid, zinc salt 3 14351-66-7 Abietic acids, sodium salts 3 123-86-4 Acetic acid, butyl ester 3 108419-35-8 Acetic acid, C11-14 branched, alkyl ester 3 90438-79-2 Acetic acid, C6-8-branched alkyl esters 3 108419-32-5 Acetic acid, C7-9 branched, alkyl ester C8-rich 3 2016-56-0 Acetic acid, dodecylamine salt 3 110-19-0 Acetic acid, isobutyl ester 3 141-97-9 Acetoacetic acid, ethyl ester 3 93-08-3 2'- Acetonaphthone 3 67-64-1 Acetone 3 828-00-2 6- Acetoxy-2,4-dimethyl-m-dioxane 3 32388-55-9 Acetyl cedrene 3 1506-02-1 6- Acetyl-1,1,2,4,4,7-hexamethyl tetralin 3 21145-77-7 Acetyl-1,1,3,4,4,6-hexamethyltetralin 3 61788-48-5 Acetylated lanolin 3 74-86-2 Acetylene 3 141754-64-5 Acrylic acid, isopropanol telomer, ammonium salt 3 25136-75-8 Acrylic acid, polymer with acrylamide and diallyldimethylam 3 25084-90-6 Acrylic acid, t-butyl ester, polymer with ethylene 3 25036-25-3 Acrylonitrile-methyl methacrylate-vinylidene chloride copoly 3 1406-16-2 Activated ergosterol 3 124-04-9 Adipic acid 3 9010-89-3 Adipic acid, polymer with diethylene glycol 3 9002-18-0 Agar 3 61791-56-8 beta- Alanine, N-(2-carboxyethyl)-, N-tallow alkyl derivs., disodium3 14960-06-6 beta- Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt 3 Alanine, N-coco alkyl derivs.
    [Show full text]
  • The Effects of New Zealand Grown Ginseng Fractions on Cytokine Production from Human Monocytic THP-1 Cells
    molecules Article The Effects of New Zealand Grown Ginseng Fractions on Cytokine Production from Human Monocytic THP-1 Cells Wei Chen 1,2,3 , Prabhu Balan 2,3 and David G. Popovich 1,* 1 School of Food and Advanced Technology, Massey University, Palmerston North 4442, New Zealand; [email protected] 2 Riddet Institute, Massey University, Palmerston North 4442, New Zealand; [email protected] 3 Alpha-Massey Natural Nutraceutical Research Centre, Massey University, Palmerston North 4442, New Zealand * Correspondence: [email protected]; Tel.: +64-63569099 Abstract: Pro-inflammatory cytokines and anti-inflammatory cytokines are important mediators that regulate the inflammatory response in inflammation-related diseases. The aim of this study is to eval- uate different New Zealand (NZ)-grown ginseng fractions on the productions of pro-inflammatory and anti-inflammatory cytokines in human monocytic THP-1 cells. Four NZ-grown ginseng fractions, including total ginseng extract (TGE), non-ginsenoside fraction extract (NGE), high-polar ginsenoside fraction extract (HPG), and less-polar ginsenoside fraction extract (LPG), were prepared and the gin- senoside compositions of extracts were analyzed by HPLC using 19 ginsenoside reference standards. The THP-1 cells were pre-treated with different concentrations of TGE, NGE, HPG, and LPG, and were then stimulated with lipopolysaccharide (LPS). The levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and anti-inflammatory cytokines, such as interleukin-10 (IL-10), and transforming growth factor beta-1 (TGF-β1), were determined by enzyme-linked immunosorbent assay (ELISA).
    [Show full text]
  • Effect of Calcium Source and Exposure-Time on Basic Caviar Spherification Using Sodium Alginate
    Available online at www.sciencedirect.com International Journal of Gastronomy and Food Science International Journal of Gastronomy and Food Science 1 (2012) 96–100 www.elsevier.com/locate/ijgfs Scientific Paper Effect of calcium source and exposure-time on basic caviar spherification using sodium alginate P. Lee, M.A. Rogersn School of Environmental and Biological Sciences, Department of Food Science, Rutgers University, The State University of New Jersey, New Brunswick, NJ 08901, USA Received 24 February 2013; accepted 12 June 2013 Available online 21 June 2013 Abstract Gelation speed is directly proportional to the concentration of calcium. Although the kinetics of gelation are altered by the source of calcium, the final alginate gel strength nor the resistance to calcium diffusion are altered. Calcium chloride reaches a gel strength plateau fastest (100 s), followed by calcium lactate (500 s) and calcium gluconoate (2000 s). Calcium chloride is the best option when the bitter taste can be masked and a fast throughput is required, while calcium gluconoate may have an advantage when the membrane thickness/hardness needs to be manipulated. & 2013 AZTI-Tecnalia. Production and hosting by Elsevier B.V. All rights reserved. Keywords: Spherification; Calcium chloride; Calcium lactate; Calcium gluconate; Sodium alginate Introduction typically contain a physical outer gel membrane with a liquid core. Spherification, an old technique in the world of modernist Alginates are an attractive ingredient because they are cuisine, was pioneered at El Bulli in 2003 and is a cornerstone derived from marine brown algae (Mabeau and Fleurence, in experimental kitchens across the world (Vega and Castells, 1993) making them non-toxic, biodegradable and naturally 2012).
    [Show full text]
  • Sodium Alginate Gel Beads
    Jelly Beads! Procedure: 1. Always wear safety goggles. 2. Rinse the beaker, graduated cylinder and petri dish. 3. Measure 20 mL of calcium chloride solution with the graduated cylinder. Add it to the beaker. 4. Add three or four drops of sodium alginate to the beaker. What happened? 5. Use the scoop to transfer one or two of the alginate gel beads from the beaker to the petri dish. Leave the rest of the beads in the beaker for later. 6. • Rinse the beads in the petri dish with water. • Touch the beads. • Lightly roll and squeeze them between your fingers. What do they feel like? What could you use them for? 7. After at least a minute has passed, use the scoop to transfer another bead or two from the beaker to the petri dish. 8. Rinse these beads, and then feel them. Do they feel any different from the beads that you pulled out earlier? Why? 9. When you are finished experimenting, dump the beads and water in the waste container. Clean up for the next person. How did the alginate drops turn into jelly beads? How could you use the beads? A Closer Look: In this experiment you created a gel out of sodium alginate. A gel is a soft substance that has the properties of both liquids and solids. In this experiment, long chains of repeating molecules in the alginate – called polymers – became tangled into a net or mesh. How did it work? When you added calcium chloride, the calcium ions in the solution cross- linked the polymers in the alginate, attaching them to each other at many points.
    [Show full text]
  • Nutraceuticals and Their Health Benefits
    Available online at www.ijpab.com Swaroopa and Srinath Int. J. Pure App. Biosci. 5 (4): 1151-1155 (2017) ISSN: 2320 – 7051 DOI: http://dx.doi.org/10.18782/2320-7051.5407 ISSN: 2320 – 7051 Int. J. Pure App. Biosci. 5 (4): 1151-1155 (2017) Review Article Nutraceuticals and their Health Benefits Swaroopa G.1* and Srinath D.2 1&2Department of Foods & Nutrition, Post Graduate and Research Centre, Professor Jayashankar Telangana State Agricultural University, Hyderabad, Telangana-500030, India *Corresponding Author E-mail: [email protected] Received: 3.08.2017 | Revised: 11.08.2017 | Accepted: 12.08.2017 ABSTRACT Nutraceuticals are products derived from food sources that are purported to provide extra health benefits, in addition to the basic nutritional value found in foods. Nutraceutical are a food or part of food that provides health benefits including the intervention and treatment of a disease. Nutraceuticals improve the health status of individuals by modulating the body functions. Different types of those nutraceuticals are available in general viz., proteins, vitamins, minerals, and other pure food compounds like., dietary supplement, herbals, nutrients, medical foods, functional foods. Nutraceuticals have attracted considerable interest due to their potential nutritional, safety and therapeutic effects. Key words: Nutraceutical, Health, Food, Disease, Nutrition. INTRODUCTION foods, herbal products and processed foods The term nutraceutical was coined from such as cereals, soups, and beverages4,8&9. nutrition and pharmaceutical in 1989 by HISTORY OF NUTRACEUTICALS Stephen Defelice, founder and chairman of The concept of Nutraceuticals went back three foundation for innovation in medicine, an thousand years ago. Hippocrates (460-377 American organization which encourages B.C) stated „let food be thy medicine and medical health1, 2, 3&4.
    [Show full text]
  • Solid Evidence of Ginseng-Warfarin Interaction
    www.nature.com/scientificreports OPEN Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of Received: 24 October 2016 Accepted: 5 June 2017 ginseng-warfarin interaction Published: xx xx xxxx Haiyan Dong1,2, Ji Ma1,2, Tao Li1,2, Yingying Xiao1,2, Ning Zheng1,2, Jian Liu1,2, Yu Gao1,2, Jingwei Shao1,2 & Lee Jia1,2 Recent global deregulation of ginseng as the table food raises our concern about the possible ginseng- warfarin interaction that could be life-threatening to patients who take warfarin for preventing fatal strokes and thromboembolism while using ginseng products for bioenergy recovery. Here we show that quality-control ginsenosides, extracted from ginseng and containing its major active ingredients, produce dose- and time-dependent antagonism in rats against warfarin’s anti-coagulation assessed by INR and rat thrombosis model. The interactions between ginsenosides and warfarin on thrombosis, pharmacokinetics, activities of coagulation factors and liver cytochrome P450 isomers are determined by using thrombosis analyzer, UPLC/MS/MS, ELISA and real-time PCR, respectively. The antagonism correlates well with the related pharmacokinetic interaction showing that the blood plateaus of warfarin reached by one-week warfarin administration are significantly reduced after three-week co-administration of warfarin with ginsenosides while 7-hydroxywarfarin is increased. The one-week warfarin and three-week warfarin-ginsenosides regimen result in restoring the suppressed levels by warfarin of the coagulating factors II, VII and protein Z, and significantly enhance activities of P450 3A4 and 2C9 that metabolize warfarin. The present study, for the first time, provides the solid evidence to demonstrate the warfarin-ginsenoside interaction, and warns the warfarin users and regulation authorities of the dangerous interaction.
    [Show full text]
  • Vitamins & Dietary Supplements Market Trends Overview
    Vitamins & Dietary Supplements Market trends - Overview PwC Deals Contents 01. Nutraceuticals Market 3 02. Vitamins & Dietary Supplements Market - Historical trend 7 03. Vitamins & Dietary Supplements Market - Outlook trend 15 PwC | Vitamins & Dietary Supplements Market trends Overview 2 01. Nutraceuticals Market Nutraceutical, Cosmeceutical and Nutra-cosmetical markets are born as Nutraceuticals Market innovative and transversal segments to the Pharmaceutical, Nutrition and Vitamins & Dietary Supplements Market Personal Care, blurring the boundaries among traditional segments Historical trend Vitamins & Dietary Supplements Market Outlook trend • Healthcare (Nutrition and Pharmaceutical) and Cosmeceutical Nutraceutical Personal Care markets have evolved in recent • Nutraceutical products are usually years, extending the focus of their business to new • The products are usually made up of vitamins, herbs, oils and used for preventive purposes areas and addressing common consumer needs. extracts • They can be used as a Pharmaceutical support for • The expansion of the business, together with the • Companies can declare that the pharmacological treatments latest industry trends, has developed transversal products have medical • They do not require a properties if they possess and innovative market segments, focused on prescription offering health and wellness benefits using natural specific characteristics required by law • Companies can declare that the ingredients and resources (e.g. food, herbs, roots, Cosmetics/ products have medical
    [Show full text]
  • Research Article Quality of Cucumbers Commercially Fermented in Calcium Chloride Brine Without Sodium Salts
    Hindawi Journal of Food Quality Volume 2018, Article ID 8051435, 13 pages https://doi.org/10.1155/2018/8051435 Research Article Quality of Cucumbers Commercially Fermented in Calcium Chloride Brine without Sodium Salts Erin K. McMurtrie1 and Suzanne D. Johanningsmeier 2 1 Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, 400 Dan Allen Drive, Raleigh, NC 27695-7642, USA 2USDA-ARS,SEAFoodScienceResearchUnit,322SchaubHall,Box7624,NorthCarolinaStateUniversity, Raleigh, NC 27695-7624, USA Correspondence should be addressed to Suzanne D. Johanningsmeier; [email protected] Received 1 October 2017; Revised 5 December 2017; Accepted 20 December 2017; Published 26 March 2018 Academic Editor: Susana Fiszman Copyright © 2018 Erin K. McMurtrie. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Dr. Suzanne D. Johanningsmeier’s contribution to this article is a work of the United States Government, for which copyright protection is not available in the United States. 17 U.S.C. §105. Commercial cucumber fermentation produces large volumes of salty wastewater. Tis study evaluated the quality of fermented cucumbers produced commercially using an alternative calcium chloride (CaCl2) brining process. Fermentation conducted in calcium brines (0.1 M CaCl2, 6 mM potassium sorbate, equilibrated) with a starter culture was compared to standard industrial fermentation. Production variables included commercial processor (� = 6), seasonal variation (June–September, 2 years), vessel size (10,000–40,000 L), cucumber size (2.7–5.1 cm diameter), and bulk storage time (55–280 days). Cucumber mesocarp frmness, color, bloater defects, pH, and organic acids were measured.
    [Show full text]
  • Panax Ginseng
    Cognitive Vitality Reports® are reports written by neuroscientists at the Alzheimer’s Drug Discovery Foundation (ADDF). These scientific reports include analysis of drugs, drugs-in- development, drug targets, supplements, nutraceuticals, food/drink, non-pharmacologic interventions, and risk factors. Neuroscientists evaluate the potential benefit (or harm) for brain health, as well as for age-related health concerns that can affect brain health (e.g., cardiovascular diseases, cancers, diabetes/metabolic syndrome). In addition, these reports include evaluation of safety data, from clinical trials if available, and from preclinical models. Panax ginseng Evidence Summary Some studies have shown that ginseng improves cognitive functions and decreases mortality and cancer risk in humans; safe when taken alone, but some drug interactions are known. Neuroprotective Benefit: Numerous studies have reported cognitive benefit with ginseng in healthy people as well as in dementia patients, but the evidence remains inconclusive due to the lack of large, long-term well-designed trials. Aging and related health concerns: Ginseng intake is associated with lower risks for mortality and cancers; also, some benefits seen in Asian people with ischemic heart disease, diabetes, hypertension, hypercholesteremia, and fatigue. Safety: Numerous meta-analyses have reported that ginseng is generally safe when taken alone; however, ginseng interacts with several medications. 1 Availability: OTC. No Dose: 200-400 mg/day Chemical formula: e.g., C42H72O14 pharmaceutical
    [Show full text]
  • Nutraceuticals: Transformation of Conventional Foods Into Health Promoters/Disease Preventers and Safety Considerations
    molecules Review Nutraceuticals: Transformation of Conventional Foods into Health Promoters/Disease Preventers and Safety Considerations Mudhi AlAli 1, Maream Alqubaisy 1, Mariam Nasser Aljaafari 1, Asma Obaid AlAli 1, Laila Baqais 1, Aidin Molouki 2, Aisha Abushelaibi 3, Kok-Song Lai 1 and Swee-Hua Erin Lim 1,* 1 Health Sciences Division, Abu Dhabi Women’s College, Higher Colleges of Technology, Abu Dhabi 41012, United Arab Emirates; [email protected] (M.A.); [email protected] (M.A.); [email protected] (M.N.A.); [email protected] (A.O.A.); [email protected] (L.B.); [email protected] (K.-S.L.) 2 Department of Avian Disease Research and Diagnostic, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj 31585-854, Iran; [email protected] 3 Dubai Colleges, Higher Colleges of Technology, Dubai 16062, United Arab Emirates; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +971-56-389-3757 Abstract: Nutraceuticals are essential food constituents that provide nutritional benefits as well as medicinal effects. The benefits of these foods are due to the presence of active compounds such as carotenoids, collagen hydrolysate, and dietary fibers. Nutraceuticals have been found to positively Citation: AlAli, M.; Alqubaisy, M.; affect cardiovascular and immune system health and have a role in infection and cancer prevention. Aljaafari, M.N.; AlAli, A.O.; Baqais, Nutraceuticals can be categorized into different classes based on their nature and mode of action. In L.; Molouki, A.; Abushelaibi, A.; Lai, this review, different classifications of nutraceuticals and their potential therapeutic activity, such K.-S.; Lim, S.-H.E.
    [Show full text]
  • Calcium Chloride a Guide to Physical Properties Table of Contents
    Calcium Chloride A Guide to Physical Properties Table of Contents About This Guide . 1 Physical Properties of Calcium Chloride Physical Properties of Calcium Chloride and Hydrates . 2 Solubility . .2 Moisture Absorption . 6 Surface Tension . .7 Specific Heat . 8 Viscosity . 8 Summary . 9 About This Guide This guide presents information on the physical properties of calcium chloride products from Occidental Chemical Corporation (OxyChem). It is intended to complement other OxyChem literature on calcium chloride products. It is not intended to serve as a complete and comprehensive technical reference for the topics presented. It is the responsibility of the end user to determine the most appropriate way to apply this information to their specific situation. OxyChem publishes and regularly updates Material Safety Data Sheets (MSDS) for each calcium chloride product it produces. These documents provide information on health and handling precautions, safety guidelines and product status relative to various government regulations. Obtain Material Safety Data Sheets and other product and application information at www.oxycalciumchloride.com. 1 Physical Properties of Calcium Chloride The data in the physical properties tables in this section are These conditions are defined by the phase diagram laboratory results typical of the products, and should not be of the calcium chloride-water system shown in confused with, or regarded as, specifications . Figure 1. This figure can be used to determine which Literature data on the physical properties of calcium phases are expected under different temperature and chloride, its hydrates and solutions generally refer concentration conditions. to pure material. Pure calcium chloride, however, is Concentrated solutions of calcium chloride have a only available in smaller quantities from chemical marked tendency to supercool; i.e., the temperature of reagent supply houses.
    [Show full text]